2026 Q1 Portfolio Activity
In 2026 Q1, ARMISTICE CAPITAL, LLC maintained a portfolio of 469 distinct positions. The most significant new addition was UNITEDHEALTH GROUP INC, now representing 0.71% of the total fund value. They heavily accumulated shares in IMMUNOVANT INC, increasing the position by 375.3%. The fund also reduced its exposure to ISHARES TR by 56.8%.
Position History
hover any row below to update
Loading…
Total Positions
469
Quarter
2026 Q1
Top Holding
SPY (24.3%)
Top 10 Concentration
56.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 469
ARMISTICE CAPITAL, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SPY
PUT
STATE STR SPDR ...
|
PUT Option | 24.28% | 24.34% |
#1
Prev: #1
|
6.0 |
—
|
-900,000 | -30.0% |
P
S
|
2,100,000 | $1,365,714,000 |
$371.02
+101.0%
|
2014 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
IWM
PUT
ISHARES TR
|
PUT Option | 15.43% | 23.72% |
#2
Prev: #2
|
5.5 |
—
|
-4,600,000 | -56.8% |
P
S
|
3,500,000 | $868,000,000 | 2019 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 2.59% | 1.71% |
#3
3
Prev: #6
|
4.5 |
—
|
1,133,526 | 30.1% |
P
S
|
4,897,417 | $145,502,259 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 2.51% | 2.53% |
#4
1
Prev: #3
|
1.5 |
—
|
-727,420 | -26.0% |
P
S
|
2,074,449 | $141,332,210 | 2018 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 2.46% | 1.84% |
#5
1
Prev: #4
|
2.0 |
—
|
-1,122 | -0.4% |
P
S
|
264,583 | $138,501,263 | 2016 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
CALL
CYTOKINETICS IN...
|
CALL Option | 1.99% | 1.13% |
#6
4
Prev: #10
|
2.8 |
—
|
200,000 | 13.3% |
P
S
|
1,700,000 | $112,047,000 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AGIO
CALL
AGIOS PHARMACEU...
|
CALL Option | 1.92% | 0.97% |
#7
7
Prev: #14
|
2.8 |
—
|
200,000 | 6.7% |
P
S
|
3,200,000 | $108,256,000 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SUPN
SUPERNUS PHARMA...
|
Healthcare | 1.74% | 1.63% |
#8
1
Prev: #7
|
0.7 |
—
|
-868,653 | -31.4% |
P
S
|
1,895,347 | $97,970,486 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 1.70% | 1.38% |
#9
1
Prev: #8
|
1.2 |
—
|
-96,240 | -11.7% |
P
S
|
724,000 | $95,379,760 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 1.63% | 0.98% |
#10
3
Prev: #13
|
1.2 |
—
|
-320,000 | -10.5% |
P
S
|
2,716,000 | $91,882,280 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 1.57% | 1.74% |
#11
6
Prev: #5
|
0.6 |
—
|
-2,182,239 | -38.0% |
P
S
|
3,564,916 | $88,552,513 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FRPT
FRESHPET INC
|
Consumer Defensive | 1.15% | 0.94% |
#12
3
Prev: #15
|
1.0 |
—
|
-202,693 | -15.6% |
P
S
|
1,093,307 | $64,461,381 | 2015 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INCY
INCYTE CORP
|
Healthcare | 1.10% | 1.29% |
#13
4
Prev: #9
|
0.4 |
—
|
-441,285 | -40.2% |
P
S
|
656,817 | $61,819,616 | 2017 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.02% | 0.76% |
#14
5
Prev: #19
|
0.9 |
—
|
-74,598 | -2.3% |
P
S
|
3,175,110 | $57,564,744 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AMZN
AMAZON COM INC
|
Consumer Cyclical | 0.97% | 1.01% |
#15
4
Prev: #11
|
0.4 |
—
|
-105,496 | -28.7% |
P
S
|
262,137 | $54,595,273 | 2017 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IRWD
IRONWOOD PHARMA...
|
Healthcare | 0.94% | 0.64% |
#16
7
Prev: #23
|
0.9 |
—
|
-997,000 | -6.2% |
P
S
|
15,028,000 | $52,748,280 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 0.90% | 0.75% |
#17
3
Prev: #20
|
0.4 |
—
|
-228,228 | -23.0% |
P
S
|
764,538 | $50,390,700 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMVT
CALL
IMMUNOVANT INC
|
CALL Option | 0.84% | 0.23% |
#18
55
Prev: #73
|
3.3 |
—
|
1,150,000 | 153.3% |
P
S
|
1,900,000 | $47,196,000 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.81% | 0.22% |
#19
55
Prev: #74
|
3.3 |
—
|
1,124,000 | 224.8% |
P
S
|
1,624,000 | $45,488,240 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 0.80% | 0.43% |
#20
16
Prev: #36
|
2.8 |
—
|
28,653 | 45.6% |
P
S
|
91,491 | $44,970,571 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.74% | 0.30% |
#21
32
Prev: #53
|
0.8 |
—
|
-18,000 | -3.0% |
P
S
|
578,000 | $41,587,100 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 0.71% | — |
#22
Prev: #—
|
3.8 |
—
|
148,000 | — |
NEW
|
148,000 | $40,047,320 | 2019 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UBER
UBER TECHNOLOGI...
|
Technology | 0.66% | 0.27% |
#23
37
Prev: #60
|
3.3 |
—
|
236,026 | 83.5% |
P
S
|
518,760 | $37,314,407 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.64% | 0.45% |
#24
11
Prev: #35
|
2.3 |
—
|
90,000 | 8.2% |
P
S
|
1,188,000 | $35,818,200 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XRAY
DENTSPLY SIRONA...
|
Healthcare | 0.62% | 0.99% |
#25
13
Prev: #12
|
0.2 |
—
|
-4,298,000 | -58.9% |
P
S
|
3,000,000 | $34,800,000 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RIGL
RIGEL PHARMACEU...
|
Healthcare | 0.62% | 0.43% |
#26
14
Prev: #40
|
3.2 |
—
|
444,000 | 53.1% |
P
S
|
1,280,000 | $34,611,200 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.61% | 0.47% |
#27
7
Prev: #34
|
2.2 |
—
|
36,609 | 7.3% |
P
S
|
536,000 | $34,271,840 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GOOGL
ALPHABET INC
|
Communication Services | 0.61% | 0.73% |
#28
7
Prev: #21
|
0.2 |
—
|
-77,906 | -39.7% |
P
S
|
118,514 | $34,079,886 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.57% | 0.29% |
#29
27
Prev: #56
|
3.2 |
—
|
499,965 | 74.0% |
P
S
|
1,176,000 | $31,857,840 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HUBS
HUBSPOT INC
|
Technology | 0.56% | 0.32% |
#30
20
Prev: #50
|
3.2 |
—
|
60,583 | 89.1% |
P
S
|
128,583 | $31,387,110 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AXGN
AXOGEN INC
|
Healthcare | 0.55% | 0.36% |
#31
16
Prev: #47
|
1.2 |
—
|
no change | no change |
P
S
|
936,000 | $31,009,680 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
OFIX
ORTHOFIX MED IN...
|
Healthcare | 0.55% | 0.48% |
#32
Prev: #32
|
0.7 |
—
|
52,000 | 2.0% |
P
S
|
2,700,000 | $30,969,000 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 0.54% | 0.61% |
#33
9
Prev: #24
|
0.2 |
—
|
-1,200,000 | -24.3% |
P
S
|
3,736,000 | $30,373,680 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVNS
AVANOS MED INC
|
Healthcare | 0.50% | 0.43% |
#34
5
Prev: #39
|
0.2 |
—
|
-1,200,000 | -37.5% |
P
S
|
2,000,000 | $28,020,000 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.50% | 0.77% |
#35
17
Prev: #18
|
0.2 |
—
|
-47,874 | -57.0% |
P
S
|
36,126 | $27,912,393 | 2017 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALGN
ALIGN TECHNOLOG...
|
Healthcare | 0.48% | 0.14% |
#36
60
Prev: #96
|
3.2 |
—
|
81,855 | 107.6% |
P
S
|
157,959 | $27,078,911 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PTCT
CALL
PTC THERAPEUTIC...
|
CALL Option | 0.47% | — |
#37
Prev: #—
|
3.7 |
—
|
390,000 | — |
NEW
|
390,000 | $26,570,700 | 2018 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MDB
MONGODB INC
|
Technology | 0.47% | 0.25% |
#38
29
Prev: #67
|
3.2 |
—
|
58,152 | 118.3% |
P
S
|
107,296 | $26,262,842 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BABA
ALIBABA GROUP H...
|
Consumer Cyclical | 0.46% | 0.56% |
#39
10
Prev: #29
|
0.2 |
—
|
-115,100 | -36.1% |
P
S
|
204,000 | $25,593,840 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MDLN
MEDLINE INC
|
Healthcare | 0.45% | 0.03% |
#40
113
Prev: #153
|
3.2 |
—
|
506,841 | 873.6% |
P
S
|
564,857 | $25,136,137 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 0.44% | 0.15% |
#41
50
Prev: #91
|
3.2 |
—
|
436,000 | 54.5% |
P
S
|
1,236,000 | $24,880,680 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DDOG
DATADOG INC
|
Technology | 0.44% | 0.40% |
#42
1
Prev: #43
|
0.7 |
—
|
-35,973 | -14.7% |
P
S
|
208,564 | $24,620,980 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HUM
HUMANA INC
|
Healthcare | 0.44% | 0.22% |
#43
32
Prev: #75
|
3.2 |
—
|
69,582 | 97.1% |
P
S
|
141,279 | $24,496,366 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
S
SENTINELONE INC
|
Technology | 0.43% | 0.43% |
#44
7
Prev: #37
|
0.2 |
—
|
-524,370 | -21.6% |
P
S
|
1,897,849 | $24,444,295 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 0.43% | 0.32% |
#45
4
Prev: #49
|
2.7 |
—
|
1,056,000 | 29.9% |
P
S
|
4,592,000 | $24,337,600 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FIVN
FIVE9 INC
|
Technology | 0.43% | 0.48% |
#46
13
Prev: #33
|
0.2 |
—
|
-408,000 | -20.4% |
P
S
|
1,592,000 | $24,150,640 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 0.43% | 0.41% |
#47
5
Prev: #42
|
0.7 |
—
|
-9,030 | -14.8% |
P
S
|
52,043 | $23,991,303 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GRFS
GRIFOLS S A
|
Healthcare | 0.43% | 0.31% |
#48
4
Prev: #52
|
2.2 |
—
|
220,000 | 7.9% |
P
S
|
2,988,000 | $23,963,760 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PENN
PENN ENTERTAINM...
|
Consumer Cyclical | 0.42% | 0.54% |
#49
18
Prev: #31
|
0.2 |
—
|
-1,518,000 | -49.0% |
P
S
|
1,578,000 | $23,717,340 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 0.41% | 0.18% |
#50
37
Prev: #87
|
2.7 |
—
|
588,000 | 22.5% |
P
S
|
3,200,000 | $23,040,000 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 469 holdings